1. CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance. (20th March 2016) Authors: Petersen, Max C.; Jurczak, Michael J. Journal: Journal of physiology Issue: Volume 594:Number 12(2016:Jun.) Page Start: 3171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypeptide, and glucagon receptor poly‐agonists: a new era in obesity pharmacotherapy. Issue 9 (24th July 2022) Authors: Malik, Is‐haq O.; Petersen, Max C.; Klein, Samuel Journal: Obesity Issue: Volume 30:Issue 9(2022) Page Start: 1718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rebuttal from Max C. Petersen and Michael J. Jurczak. (20th March 2016) Authors: Petersen, Max C.; Jurczak, Michael J. Journal: Journal of physiology Issue: Volume 594:Number 12(2016:Jun.) Page Start: 3177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance. (July 2017) Authors: Petersen, Max C.; Shulman, Gerald I. Journal: Trends in pharmacological sciences Issue: Volume 38:Number 7(2017) Page Start: 649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗